Navidea Biopharm Enters Agreement With Alseres to Terminate NAV5001 Sub-License Agreement
April 27, 2015 at 07:32 AM EDT
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today announced that it has entered into an agreement with Alseres Pharmaceuticals, ...
